Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.29 | 0.29 | 0.00 |
Shares | 90.55 | 90.55 | 0.00 |
Convertible | 0.13 | 0.13 | 0.00 |
Preferred | 0.01 | 0.01 | 0.00 |
Other | 9.02 | 9.02 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.33 | 19.67 |
Price to Book | 4.89 | 4.69 |
Price to Sales | 2.25 | 2.69 |
Price to Cash Flow | 20.49 | 18.26 |
Dividend Yield | 0.74 | 1.06 |
5 Years Earnings Growth | 19.92 | 17.36 |
Number of long holdings: 141
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.48 | 765.10 | -2.16% | |
Aggregate Miscellaneous Equity | - | 9.02 | - | - | |
UnitedHealth | US91324P1021 | 7.38 | 513.67 | +0.13% | |
Intuitive Surgical | US46120E6023 | 5.07 | 542.37 | +1.32% | |
Thermo Fisher Scientific | US8835561023 | 4.64 | 537.19 | +0.97% | |
Danaher | US2358511028 | 3.79 | 238.20 | +1.43% | |
Stryker | US8636671013 | 3.70 | 361.36 | -0.04% | |
argenx ADR | US04016X1019 | 3.23 | 645.37 | +3.88% | |
Merck&Co | US58933Y1055 | 2.57 | 99.72 | +0.59% | |
Vertex | US92532F1003 | 2.56 | 402.49 | -1.13% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 35.09B | 15.10 | 7.45 | 10.77 | ||
T. Rowe Price Blue Chip Growth | 32.6B | 36.09 | 7.62 | 14.78 | ||
T. Rowe Price Blue Chip Growth I | 29.84B | 36.24 | 7.76 | - | ||
T. Rowe Price Capital AppreciationI | 28.77B | 15.25 | 7.60 | - | ||
T. Rowe Price Instl Large Cap Growt | 22.6B | 32.75 | 8.37 | 16.17 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review